Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
2.170
-0.025 (-1.14%)
At close: Nov 14, 2025, 4:00 PM EST
2.160
-0.010 (-0.46%)
After-hours: Nov 14, 2025, 5:08 PM EST
Kiora Pharmaceuticals Market Cap
Kiora Pharmaceuticals has a market cap or net worth of $7.92 million as of November 14, 2025. Its market cap has decreased by -27.98% in one year.
Market Cap
7.92M
Enterprise Value
-11.05M
1-Year Change
-27.98%
Ranking
Category
Stock Price
$2.17
Market Cap Chart
Since February 13, 2015, Kiora Pharmaceuticals's market cap has decreased from $38.90M to $7.92M, a decrease of -79.63%. That is a compound annual growth rate of -13.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 7.90M | -20.20% |
| Dec 31, 2024 | 9.90M | 147.50% |
| Dec 29, 2023 | 4.00M | 2.56% |
| Dec 30, 2022 | 3.90M | -79.58% |
| Dec 31, 2021 | 19.10M | -16.23% |
| Dec 31, 2020 | 22.80M | -37.36% |
| Dec 31, 2019 | 36.40M | 80.20% |
| Dec 31, 2018 | 20.20M | 9.78% |
| Dec 29, 2017 | 18.40M | 17.95% |
| Dec 30, 2016 | 15.60M | -25.71% |
| Dec 31, 2015 | 21.00M | -46.02% |
| Feb 13, 2015 | 38.90M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 915.86B |
| Johnson & Johnson | 470.41B |
| AbbVie | 410.55B |
| UnitedHealth Group | 301.21B |
| AstraZeneca | 276.17B |
| Novartis AG | 256.16B |
| Merck & Co. | 230.65B |
| Abbott Laboratories | 224.77B |